Clinical trial
Benzocaine Gel Toothache Dose-Response Study
NCT00474175 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00474175 |
|---|---|
| Title | Benzocaine Gel Toothache Dose-Response Study |
| Official title | Benzocaine Gel Toothache Dose-Response Study |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Collaborators | Church & Dwight Company, Inc. Industry Consumer Healthcare Products Association |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Toothache |
| Intervention type | Drug |
| Interventions | Placebo gel, benzocaine |
| Enrollment | 577 |
| Start date | May 1, 2007 |
| Primary completion | Dec 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | May 16, 2007 |
| Last update posted | Feb 28, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: